Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized

Key Record Dates Identifier: NCT05185531
Brief Title: A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma (Notable-HCC)

First Submitted : December 19, 2021
First Submitted that Met QC Criteria : January 5, 2022
First Posted : January 11, 2022

Last Update Submitted that Met QC Criteria : November 16, 2022
Last Update Posted : November 21, 2022